Buspirone Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (5mg, 10mg, 15mg, 30mg); Application (Anxiety, Psychosis, Others); End User (Hospitals, Clinics, Others) and Geography

Report Code: TIPRE00019745 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Buspirone is an agent used to treat anxiety and all related generalized anxiety disorders. Buspirone is developed as a Spiro compound and is available in generic form. Other therapeutic effects of buspirone includes, treatment of sexual dysfunction and rare cases of alcohol withdrawal. Side effects of buspirone include, headache, nausea, dizziness, hallucinations and seizures.

MARKET DYNAMICS

The Buspirone market is anticipated to grow in the forecast period owing to factors such as, increasing prevalence of neurologic disorders such as, anxiety, psychosis, and bipolar disorders along with rising geriatric population across the globe. Moreover, high R&D investments by drug companies to develop novel treatment therapies is also expected to fuel market growth during forecast period. Whereas, high prevalence of side effects from buspirone is expected to restrain market growth during forecast period.

MARKET SCOPE

The "Buspirone Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Buspirone market with detailed market segmentation by product, application and end user. The Buspirone Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Buspirone Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Buspirone Market is segmented on the basis of product, application and end user. On the basis of product the market is segmented as, 5MG, 10MG, 15 MG and 30MG tablets. On the basis of application the market is segmented as, anxiety, psychosis and others. On the basis of end user the market is bifurcated as, clinics, hospitals and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Buspirone Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Buspirone Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Buspirone Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Buspirone Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Buspirone Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Buspirone Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Buspirone market in the global market. Below mentioned is the list of few companies engaged in the Buspirone Market.

The report also includes the profiles of key players in Buspirone Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Bristol Myers Squibb
  •   Apotex
  •   DR. Reddy's Laboratories
  •   Laboratoires Servier
  •   Teva
  •   AMAG Pharmaceuticals
  •   Mylan
  •   Novartis
  •   Hikma
  •   Cadila Healthcare

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Buspirone Market - By Product
1.3.2 Buspirone Market - By Application
1.3.3 Buspirone Market - By End User
1.3.4 Buspirone Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BUSPIRONE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BUSPIRONE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BUSPIRONE MARKET - GLOBAL MARKET ANALYSIS
6.1. BUSPIRONE - GLOBAL MARKET OVERVIEW
6.2. BUSPIRONE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. BUSPIRONE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. 5MG
7.3.1. Overview
7.3.2. 5mg Market Forecast and Analysis
7.4. 10MG
7.4.1. Overview
7.4.2. 10mg Market Forecast and Analysis
7.5. 15MG
7.5.1. Overview
7.5.2. 15mg Market Forecast and Analysis
7.6. 30MG
7.6.1. Overview
7.6.2. 30mg Market Forecast and Analysis
8. BUSPIRONE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ANXIETY
8.3.1. Overview
8.3.2. Anxiety Market Forecast and Analysis
8.4. PSYCHOSIS
8.4.1. Overview
8.4.2. Psychosis Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. BUSPIRONE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. BUSPIRONE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Buspirone Market Overview
10.1.2 North America Buspirone Market Forecasts and Analysis
10.1.3 North America Buspirone Market Forecasts and Analysis - By Product
10.1.4 North America Buspirone Market Forecasts and Analysis - By Application
10.1.5 North America Buspirone Market Forecasts and Analysis - By End User
10.1.6 North America Buspirone Market Forecasts and Analysis - By Countries
10.1.6.1 United States Buspirone Market
10.1.6.1.1 United States Buspirone Market by Product
10.1.6.1.2 United States Buspirone Market by Application
10.1.6.1.3 United States Buspirone Market by End User
10.1.6.2 Canada Buspirone Market
10.1.6.2.1 Canada Buspirone Market by Product
10.1.6.2.2 Canada Buspirone Market by Application
10.1.6.2.3 Canada Buspirone Market by End User
10.1.6.3 Mexico Buspirone Market
10.1.6.3.1 Mexico Buspirone Market by Product
10.1.6.3.2 Mexico Buspirone Market by Application
10.1.6.3.3 Mexico Buspirone Market by End User
10.2. EUROPE
10.2.1 Europe Buspirone Market Overview
10.2.2 Europe Buspirone Market Forecasts and Analysis
10.2.3 Europe Buspirone Market Forecasts and Analysis - By Product
10.2.4 Europe Buspirone Market Forecasts and Analysis - By Application
10.2.5 Europe Buspirone Market Forecasts and Analysis - By End User
10.2.6 Europe Buspirone Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Buspirone Market
10.2.6.1.1 Germany Buspirone Market by Product
10.2.6.1.2 Germany Buspirone Market by Application
10.2.6.1.3 Germany Buspirone Market by End User
10.2.6.2 France Buspirone Market
10.2.6.2.1 France Buspirone Market by Product
10.2.6.2.2 France Buspirone Market by Application
10.2.6.2.3 France Buspirone Market by End User
10.2.6.3 Italy Buspirone Market
10.2.6.3.1 Italy Buspirone Market by Product
10.2.6.3.2 Italy Buspirone Market by Application
10.2.6.3.3 Italy Buspirone Market by End User
10.2.6.4 Spain Buspirone Market
10.2.6.4.1 Spain Buspirone Market by Product
10.2.6.4.2 Spain Buspirone Market by Application
10.2.6.4.3 Spain Buspirone Market by End User
10.2.6.5 United Kingdom Buspirone Market
10.2.6.5.1 United Kingdom Buspirone Market by Product
10.2.6.5.2 United Kingdom Buspirone Market by Application
10.2.6.5.3 United Kingdom Buspirone Market by End User
10.2.6.6 Rest of Europe Buspirone Market
10.2.6.6.1 Rest of Europe Buspirone Market by Product
10.2.6.6.2 Rest of Europe Buspirone Market by Application
10.2.6.6.3 Rest of Europe Buspirone Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Buspirone Market Overview
10.3.2 Asia-Pacific Buspirone Market Forecasts and Analysis
10.3.3 Asia-Pacific Buspirone Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Buspirone Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Buspirone Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Buspirone Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Buspirone Market
10.3.6.1.1 Australia Buspirone Market by Product
10.3.6.1.2 Australia Buspirone Market by Application
10.3.6.1.3 Australia Buspirone Market by End User
10.3.6.2 China Buspirone Market
10.3.6.2.1 China Buspirone Market by Product
10.3.6.2.2 China Buspirone Market by Application
10.3.6.2.3 China Buspirone Market by End User
10.3.6.3 India Buspirone Market
10.3.6.3.1 India Buspirone Market by Product
10.3.6.3.2 India Buspirone Market by Application
10.3.6.3.3 India Buspirone Market by End User
10.3.6.4 Japan Buspirone Market
10.3.6.4.1 Japan Buspirone Market by Product
10.3.6.4.2 Japan Buspirone Market by Application
10.3.6.4.3 Japan Buspirone Market by End User
10.3.6.5 South Korea Buspirone Market
10.3.6.5.1 South Korea Buspirone Market by Product
10.3.6.5.2 South Korea Buspirone Market by Application
10.3.6.5.3 South Korea Buspirone Market by End User
10.3.6.6 Rest of Asia-Pacific Buspirone Market
10.3.6.6.1 Rest of Asia-Pacific Buspirone Market by Product
10.3.6.6.2 Rest of Asia-Pacific Buspirone Market by Application
10.3.6.6.3 Rest of Asia-Pacific Buspirone Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Buspirone Market Overview
10.4.2 Middle East and Africa Buspirone Market Forecasts and Analysis
10.4.3 Middle East and Africa Buspirone Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Buspirone Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Buspirone Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Buspirone Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Buspirone Market
10.4.6.1.1 South Africa Buspirone Market by Product
10.4.6.1.2 South Africa Buspirone Market by Application
10.4.6.1.3 South Africa Buspirone Market by End User
10.4.6.2 Saudi Arabia Buspirone Market
10.4.6.2.1 Saudi Arabia Buspirone Market by Product
10.4.6.2.2 Saudi Arabia Buspirone Market by Application
10.4.6.2.3 Saudi Arabia Buspirone Market by End User
10.4.6.3 U.A.E Buspirone Market
10.4.6.3.1 U.A.E Buspirone Market by Product
10.4.6.3.2 U.A.E Buspirone Market by Application
10.4.6.3.3 U.A.E Buspirone Market by End User
10.4.6.4 Rest of Middle East and Africa Buspirone Market
10.4.6.4.1 Rest of Middle East and Africa Buspirone Market by Product
10.4.6.4.2 Rest of Middle East and Africa Buspirone Market by Application
10.4.6.4.3 Rest of Middle East and Africa Buspirone Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Buspirone Market Overview
10.5.2 South and Central America Buspirone Market Forecasts and Analysis
10.5.3 South and Central America Buspirone Market Forecasts and Analysis - By Product
10.5.4 South and Central America Buspirone Market Forecasts and Analysis - By Application
10.5.5 South and Central America Buspirone Market Forecasts and Analysis - By End User
10.5.6 South and Central America Buspirone Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Buspirone Market
10.5.6.1.1 Brazil Buspirone Market by Product
10.5.6.1.2 Brazil Buspirone Market by Application
10.5.6.1.3 Brazil Buspirone Market by End User
10.5.6.2 Argentina Buspirone Market
10.5.6.2.1 Argentina Buspirone Market by Product
10.5.6.2.2 Argentina Buspirone Market by Application
10.5.6.2.3 Argentina Buspirone Market by End User
10.5.6.3 Rest of South and Central America Buspirone Market
10.5.6.3.1 Rest of South and Central America Buspirone Market by Product
10.5.6.3.2 Rest of South and Central America Buspirone Market by Application
10.5.6.3.3 Rest of South and Central America Buspirone Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BUSPIRONE MARKET, KEY COMPANY PROFILES
12.1. BRISTOL MYERS SQUIBB
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. APOTEX
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DR. REDDY'S LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. LABORATOIRES SERVIER
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TEVA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. AMAG PHARMACEUTICALS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MYLAN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HIKMA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CADILA HEALTHCARE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bristol Myers Squibb
2. Apotex
3. Dr. Reddy's Laboratories
4. Laboratoires Servier
5. Teva
6. AMAG Pharmaceuticals
7. Mylan
8. Novartis
9. Hikma
10. Cadila Healthcare
TIPRE00019745
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking